Win Coat Corporation, also known as 怡定興科技股份有限公司, is a high-tech biotechnology company founded in 2014. As a leader in the Asia-Pacific region, the company offers advanced biomedical products with a focus on transdermal microneedle systems. These systems provide a painless and effective drug delivery platform, revolutionizing the way medication is administered.

Unlike traditional methods, their patch contains hundreds of microneedles that penetrate the skin to release the medication, bypassing the barrier of the stratum corneum. This approach improves the bioavailability of the drug, regardless of its solubility. With their unique multi-layer microneedle production technology and FDA-approved medical-grade materials, Win Coat Corporation produces microarray patches for various applications, including medical aesthetics, medical devices, pharmaceuticals, and vaccines.

They have established a production capacity to manufacture thousands of patches per day, ensuring a high yield rate of over 95%. With their cutting-edge technology and commitment to innovation, Win Coat Corporation aims to improve healthcare outcomes and positively impact the lives of people worldwide